Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 55289-090

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 55289-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (55289090)

The label for Triamterene and Hydrochlorothiazide USP tablets, strength 37.5 mg/25 mg, contains 30 tablets. The product is labeled by PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK. The label includes dosage and storage warnings, a reorder number, lot number J19D80, expiration date 10/2021, and patient instructions sections for dosage. It features barcodes, a QR code, and is mostly black and white with a green header strip.*

FDA Label Image

Image 1

Chemical structure of the active ingredient Triamterene, showing a fused ring system with multiple nitrogen atoms and an attached phenyl group.*

FDA Label Image

Image 2

Chemical structure diagram depicting the molecular composition of the active ingredient Triamterene and Hydrochlorothiazide, showing functional groups and atomic connections.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.